Delivery Order SPE2DB22D1017-SPE2DB24FG2JQ

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,199.10 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 225 mg/1.5 mL autoinjector doses of the drug Ajovy. The contract has a completion date of May 12, 2025 and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,072.34 firm fixed price delivery order is for the supply of Ajovy 225 mg/1.5 ml autoinjector medication. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2020. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $2,889.54 firm fixed price contract is for the supply of 225 mg/1.5 ml doses of the pharmaceutical product Ajovy, an autoinjector medication. The contract has a period of performance through July 23, 2024 and does not include any set-aside designation. AmerisourceBergen is a large pharmaceutical distributor that holds several Indefinite Delivery...
This contract is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,086.71 firm-fixed-price contract is for the delivery of Ajovy 225 mg/1.5 ml autoinjector medication and has an ultimate completion date of August 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, to...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The $2,103.32 delivery order is for the supply of the medication Ajovy 225 mg/1.5 ml autoinjectors to an unspecified government agency. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics support to the U.S. Armed Forces and other federal agencies. Amerisourcebergen holds a significant...
This federal contract award, valued at $1,231.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Ajovy, a 225 mg/1.5 ml syringe, with a completion date of May 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of the drug Ajovy 225 mg/1.5 ml autoinjector. The delivery order, valued at $1,638.58, has a firm fixed-price pricing type and an ultimate completion date of April 30, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,847.18 to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,355.91 firm fixed-price delivery order is for the supply of 225 mg/1.5 ml AJOVY auto-injector products. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,927.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, with a completion date of December 6, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG2JQ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ajovy 225 mg/1.5 ml autoinjector medication. The contract has a firm fixed price of $1,053.76 and a performance period ending on August 2, 2024. It is not a set-aside contract. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies for providing a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other government healthcare initiatives. The company has significant Indefinite Delivery Contracts with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, that enable efficient procurement of essential medical commodities.

Generated 10/31/24, 9:07 AM